Oct
1
Middletown, DE — (TechSonian) — 10/01/2013 –VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: EXACT Sciences Corporation (NASDAQ:EXAS), Grupo Financiero Galicia S.A. (ADR) (NASDAQ:GGAL), Dyax Corp (NASDAQ:DYAX), DragonWave, Inc (USA) (NASDAQ:DRWI)
EXACT Sciences Corporation (NASDAQ:EXAS) the 52 week range of the stock remained $6.93 – $14.70 and the day range was $11.65 – $12.32. The stock opened the session at $11.93 but then moved to $11.80. At that price, the stock showed a negative performance of -1.91%.Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The Company’s Cologuard test is a non-invasive, stool-based DNA (sDNA) screening test designed to detect deoxyribonucleic acid (DNA) markers, which in published studies have been shown to be associated with colorectal cancer. In addition to DNA markers, its test includes a protein marker to detect blood in the stool,
Will EXAS Get Buyers Even After The Recent Rally? Find Out Here
Grupo Financiero Galicia S.A. (ADR) (NASDAQ:GGAL) opened the session at $9.67 and closed the session at $9.51. The stock showed a negative performance of -1.86% in previous trading session. Traded with volume of 1.22 million shares in the prior session and the average volume of the stock remained 627,650.00 shares. Grupo Financiero Galicia SA is an Argentina-based financial services holding company. Banco de Galicia y Buenos Aires SA is the Company’s major asset, which provides a range of financial products and services to large corporations, small and medium sized companies (SMEs), and individuals. The Company operates through numerous subsidiaries,
Has GGAL Found The Bottom And Ready To Gain Momentum? Find Out Here
Dyax Corp (NASDAQ:DYAX) opened the session at $6.77 and closed the session at $6.86. The stock showed a negative performance of -0.15% in previous trading session. The beta of the stock remained 1.59. Dyax Corp. (Dyax), is a biopharmaceutical company with two business elements: Angioedema Franchise and Phage Display Licensing and Funded Research Program. It is focused on identifying and developing treatments for patients who experience plasma kallikrein (bradykinin) mediated angioedema.
Why Should Investors Buy DYAX After the Recent Fall? Just Go Here and Find Out
DragonWave, Inc (USA) (NASDAQ:DRWI) the stock advanced 7.03% and finished the session at $1.98. Traded with volume of 195,195 shares in the prior session and the average volume of the stock remained 248,913.00 shares. DragonWave Inc. (DragonWave) is in the business of developing broadband wireless backhaul and pseudowire equipment. The Company is a provider of wireless Ethernet equipment used in Internet protocol (IP) networks. DragonWave designs, develops, markets and sells carrier-grade microwave radio frequency networking equipment (referred to as links),
Will DRWI Continue To Move Higher? Find Out Here
About VipStockReports.com:
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the ‘Next Hot Penny Stock’ with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
Disclaimer:
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Open all references in tabs: [1 – 6]
Comments
Leave a Reply
You must be logged in to post a comment.